To further investigate whether C5a/C5aR pathway-induced proliferation of gastric cancer cells occurs via LCN2, we treated THP1 cells with C5a and C5a+ ZINC00640089 (an LCN2-specific inhibitor). The gene discussed is C5AR1; the disease is gastric cancer.